DGAP-News

STRATEC achieves higher sales and improved profitability in 2015

DGAP-News: STRATEC Biomedical AG / Key word(s): Final Results
STRATEC achieves higher sales and improved profitability in 2015

14.04.2016 / 07:36
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

STRATEC achieves higher sales and improved profitability in 2015

- Sales of EUR 146.9 million (+1.4%; previous year: EUR 144.9 million)
- EBIT of EUR 26.9 million (+11.7%; previous year: EUR 24.1 million)
- EBIT margin at 18.3% (+170 base points; previous year: 16.6%)
- Consolidated net income of EUR 22.1 million
(+11.7%; previous year: EUR 19.8 million)
- Earnings per share of EUR 1.87 (+11.3%; previous year: EUR 1.68)
- Proposed dividend of EUR 0.75 per share
(dividend payment previous year: EUR 0.70 per share)
- Publication of new financial forecast in 2016 half-year Interim Report

Birkenfeld, April 14, 2016

STRATEC Biomedical AG (Frankfurt: SBS; Prime Standard, TecDAX) today
announced the final audited results of the STRATEC Group for the financial
year ending December 31, 2015, with the publication of its 2015 Annual
Report. These figures prepared in line with International Financial
Reporting Standards (IFRS) have been audited and granted an unqualified
audit opinion.

Key figures
(EUR thousand)             01.01.- 31.12.2015 01.01.- 31.12.2014  Changes
Sales                                 146,886            144,860    +1.4%
EBIT                                   26,875             24,052   +11.7%
Consolidated net income                22,084             19,768   +11.7%
Earnings per share (EUR)                 1.87               1.68   +11.3%
EBIT margin (%)                          18.3               16.6 +170 bps

bps = basis points


Business performance
STRATEC achieved a growth in sales in the 2015 financial year of 1.4% over
the previous year, from EUR 144.9 million to EUR 146.9 million. The EBIT
margin was also significantly increased from 16.6% to 18.3%. This positive
development was largely attributable to the mix of products, new projects
in the workflow solutions area, and a locally beneficial development in
currency fluctuations.

Additionally, the company continued to receive a high volume of progress
payments for development services. These projects and subsequent market
launches are expected to generate the growth planned over the coming years.

The share of sales attributable to service parts increased from 23.4% in
2014 to 24.3% in 2015.

EBIT increased by 11.7% from EUR 24.1 million in the previous year to
EUR 26.9 million in the 2015 financial year, representing an EBIT margin of
18.3%. Consolidated net income grew correspondingly by 11.7% to EUR 22.1